Catalyst Wire Dossier Catalyst Wire Dossier

Kisplyx

lenvatinib mesilate · Eisai GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kisplyx, covering 2026-03-26 to 2026-03-26. Get the full timeline:

Most recent: EMA Authorised: Kisplyx (lenvatinib mesilate) — Eisai GmbH

See pricing